Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic quinazole derivatives and their use as MTKI

Macrocyclic quinazole derivatives and their use as MTKI

US Patent 9688691 · Granted Jun 27, 2017

Estimated economic value: $57,687,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds useful as inhibitors of ATR kinase2025
GCN2 inhibitors and uses thereof2024
2,4-diaminoquinazoline derivatives and medical uses thereof2023
Inhibitors of the interaction between MDM2 and P532023
Inhibitors of the interaction between MDM2 and P532023
Pyrimidine derivatives for the treatment of viral infections2023
Exo-aza spiro inhibitors of menin-MLL interaction2022
Compounds useful as inhibitors of ATR kinase2022
Substituted azaindoline derivatives as NIK inhibitors2022
Pyrrolo[3,2-d] pyrimidine derivatives for the treatment of viral infections and 2022
Substituted cyanoindoline derivatives as NIK inhibitors2021
Aryl substituted pyrimidines for use in influenza virus infection2021